Stockreport

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026 [Yahoo! Finance]

Aytu BioPharma, Inc.  (AYTU) 
NASDAQ:AMEX Investor Relations: aytubio.com/investors/stock-information
PDF advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results [Read more]